MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

NCT01299376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: L50/H12.5/A5
DRUG: L50/H12.5
DRUG: Placebo to L50/H12.5/A5
DRUG: Placebo to L50/H12.5

Sponsor

Merck Sharp & Dohme LLC